Samsara Vision’s SING IMT: Game Changer for the Advanced AMD Patient

ByJoshua Mali, MD

In this episode, I discuss Samsara Vision’s SING IMT and its benefits of vision improvement for patients with AMD with Rebecca Kammer, OD, PhD.

Brought to you by Alcon

Welcome to another exciting episode of Eye Care insider :14
Intro for Rebecca Kammer, OD, PhD :27
Dr. Kammer’s background 1:28
Defining late-stage AMD patients and treatments available 5:11
The SING IMT 9:46
US Concerto Study Website – to learn more about the study 13:13
Visual acuity and the SING IMT 13:48
US trial, recruitment and patient eligibility 17:18
Contact toll-free 1-866-393-3767 discuss eligibility, participation and questions 20:39
SING IMT as an option for patients 22:55
Thanks for listening 27:30

We’d love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN. You can reach Dr. Kammer at rkammer@samsaravision.com.

Rebecca Kammer, OD, PhD, is the vice president of worldwide clinical and medical affairs for Samsara Vision, Inc., an adjunct professor at University of California, Irvine and a diplomate in low vision of the American Academy of Optometry.

Published by:

Sources/Disclosures

Collapse

Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI. Kammer reports being a clinical advisor to Biovisics and Eyedaptic.

Read more

Samsara Vision’s SING IMT: Game Changer for the Advanced AMD Patient

Eye Care Insider

Related Content